Skip to search formSkip to main contentSkip to account menu

aluminoxamine

Known as: Aluminum, (N'-(5-((4-((5-(acetylhydroxyamino)pentyl)amino)-1,4-dioxobutyl)hydroxyamino)pentyl)-N-(5-aminopentyl)-N-hydroxybutanediamidato(3-))-, aluminum-desferrioxamine complex 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

DeferoxamineOrganometallic Compounds

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Use of ultrafiltration and chromatography to assess aluminum speciation in serum after deferoxamine administration.
Deferoxamine effectively chelates aluminum by forming aluminoxamine, a low-molecular-weight compound removable by dialysis… 
1998
1998
Low percentage of aluminoxamine and ferrioxamine in uremic serum after desferrioxamine administration.
HPLC was used to study the effectiveness of two different desferrioxamine (DFO) administration strategies (15 mg/kg DFO, 1 h or… 
1998
1998
Quantification of desferrioxamine, ferrioxamine and aluminoxamine by post-column derivatization high-performance liquid chromatography. Non-linear calibration resulting from second-order reaction…
1997
1997
Aluminium speciation in cerebrospinal fluid of acutely aluminium-intoxicated dialysis patients before and after desferrioxamine treatment; a step in the understanding of the element's neurotoxicity.
BACKGROUND The association between aluminium and dialysis encephalopathy and deterioration of the neurological state during… 
1996
1996
Estimation of statistical moments for desferrioxamine and its iron and aluminum chelates: contribution to optimisation of therapy in uremic patients.
We investigated the best time of administration of desferrioxamine (DFO) with respect to the dialysis session, using the approach… 
1992
1992
Pharmacokinetics of aluminoxamine and ferrioxamine and dose finding of desferrioxamine in haemodialysis patients.
We investigated the pharmacokinetics of desferrioxamine and its chelated compounds aluminoxamine and ferrioxamine in normal… 
1992
1992
Kinetics of aluminoxamine and feroxamine chelates in dialysis patients.
To achieve a rational basis for the use of deferoxamine (DFO) in aluminum (AL) -and iron (Fe)-overloaded uremic patients… 
1989
1989
Indirect measurement of desferrioxamine and its chelated compounds aluminoxamine and ferrioxamine by Zeeman atomic absorption spectrometry.
This indirect method for determination of desferrioxamine (DFO, deferoxamine, Desferal) and its chelated compounds ferrioxamine… 
1988
1988
Pharmacokinetics of desferrioxamine and of its iron and aluminum chelates in patients on peritoneal dialysis.
1988
1988
Effect of Aluminum and Deferoxamine on Biliary Iron Elimination in the Rat
Abstract Iron (Fe) and aluminum (Al) eliminations in bile were studied in rats after intravenous administration of Fe, Al… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)